Purdue Pharma to Settle Thousands of Opioid Lawsuits
Under a tentative deal between the OxyContin manufacturer and more than 2,000 local governments, the Purdue-owning Sackler family would reportedly pay $3 billion over seven years while their company navigates a broader structured bankruptcy. Still, the specifics of the agreement — which doesn’t include an admission that Purdue’s aggressive marketing contributed to 400,000 opioid-related deaths over two decades — have yet to be determined.
What’s next? While the agreement may help Purdue avoid an upcoming federal trial in Ohio, several state attorneys general are pressing ahead with legal offensives against the company and the Sacklers.